Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Phase 2b, Open Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered With or Without Routine Infant Vaccinations to Healthy Infants According to Different Immunization Schedules.
Meningococcal Serogroup B Vaccine
V72P12
NCT00721396
Infections, Meningococcal
Phase 2
 
An analysis-ready dataset is not available for this study. There is no GSK Clinical Study Register entry for this study.
October 2015

Powered by ideaPoint, Inc.